A detailed history of Janus Henderson Group PLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Janus Henderson Group PLC holds 447,086 shares of BMY stock, worth $22.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
447,086
Previous 455,532 1.85%
Holding current value
$22.1 Million
Previous $24.7 Million 24.84%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $339,951 - $447,553
-8,446 Reduced 1.85%
447,086 $18.6 Million
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $1.4 Million - $1.59 Million
-29,272 Reduced 6.04%
455,532 $24.7 Million
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $2.56 Million - $3.06 Million
-52,839 Reduced 9.83%
484,804 $24.9 Million
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $143 Million - $159 Million
-2,462,047 Reduced 82.08%
537,643 $31.2 Million
Q2 2023

Aug 14, 2023

SELL
$63.71 - $70.74 $41.4 Million - $45.9 Million
-649,305 Reduced 17.79%
2,999,690 $192 Million
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $158 Million - $180 Million
-2,411,228 Reduced 39.79%
3,648,995 $253 Million
Q4 2022

Feb 14, 2023

SELL
$68.48 - $81.09 $91.8 Million - $109 Million
-1,339,991 Reduced 18.11%
6,060,223 $436 Million
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $83,415 - $49.3 Million
641,655 Added 9.49%
7,400,214 $526 Million
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $183 Million - $201 Million
-2,515,628 Reduced 27.13%
6,758,559 $521 Million
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $27.4 Million - $32.9 Million
446,157 Added 5.05%
9,274,187 $677 Million
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $4.06 Million - $4.73 Million
-75,625 Reduced 0.85%
8,828,030 $550 Million
Q3 2021

Nov 16, 2021

BUY
$59.17 - $69.31 $1.12 Million - $1.31 Million
18,927 Added 0.21%
8,903,655 $527 Million
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $421 Million - $459 Million
-6,804,513 Reduced 43.37%
8,884,728 $594 Million
Q1 2021

May 17, 2021

SELL
$59.34 - $66.74 $448 Million - $504 Million
-7,548,334 Reduced 32.48%
15,689,241 $990 Million
Q4 2020

Feb 16, 2021

SELL
$57.74 - $65.43 $29.3 Million - $33.2 Million
-506,695 Reduced 2.13%
23,237,575 $1.44 Billion
Q3 2020

Nov 16, 2020

BUY
$57.43 - $63.64 $147 Million - $163 Million
2,562,329 Added 12.1%
23,744,270 $1.43 Billion
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $26.8 Million - $31.4 Million
-489,675 Reduced 2.26%
21,181,941 $1.25 Billion
Q1 2020

May 14, 2020

SELL
$46.4 - $67.43 $14.1 Million - $20.5 Million
-303,385 Reduced 1.38%
21,671,616 $1.21 Billion
Q4 2019

Feb 18, 2020

BUY
$49.21 - $64.19 $197 Million - $257 Million
4,007,086 Added 22.3%
21,975,001 $1.41 Billion
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $77.5 Million - $91.9 Million
1,811,356 Added 11.21%
17,967,915 $911 Million
Q2 2019

Jul 31, 2019

BUY
$44.62 - $49.34 $311 Million - $343 Million
6,960,047 Added 75.68%
16,156,559 $733 Million
Q1 2019

Apr 30, 2019

BUY
$45.12 - $53.8 $55.6 Million - $66.3 Million
1,231,639 Added 15.46%
9,196,512 $439 Million
Q4 2018

Feb 06, 2019

SELL
$48.76 - $63.23 $43.7 Million - $56.6 Million
-895,829 Reduced 10.11%
7,964,873 $414 Million
Q3 2018

Nov 09, 2018

BUY
$55.19 - $62.25 $107 Million - $121 Million
1,937,785 Added 27.99%
8,860,702 $550 Million
Q2 2018

Aug 10, 2018

BUY
$50.53 - $62.98 $187 Million - $233 Million
3,695,485 Added 114.5%
6,922,917 $383 Million
Q1 2018

May 14, 2018

BUY
$59.92 - $68.98 $75.4 Million - $86.8 Million
1,257,877 Added 63.87%
3,227,432 $204 Million
Q4 2017

Feb 09, 2018

SELL
$59.94 - $65.35 $39 Million - $42.5 Million
-650,400 Reduced 24.82%
1,969,555 $121 Million
Q3 2017

Nov 14, 2017

SELL
$55.23 - $63.74 $56 Million - $64.6 Million
-1,014,173 Reduced 27.91%
2,619,955 $0
Q2 2017

Aug 17, 2017

BUY
N/A
3,634,128
3,634,128 $202 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $105B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.